Literature DB >> 22086418

Contrasting dynamic responses in vivo of the Bcl-xL and Bim erythropoietic survival pathways.

Miroslav Koulnis1, Ermelinda Porpiglia, P Alberto Porpiglia, Ying Liu, Kelly Hallstrom, Daniel Hidalgo, Merav Socolovsky.   

Abstract

Survival signaling by the erythropoietin (Epo) receptor (EpoR) is essential for erythropoiesis and for its acceleration in hypoxic stress. Several apparently redundant EpoR survival pathways were identified in vitro, raising the possibility of their functional specialization in vivo. Here we used mouse models of acute and chronic stress, including a hypoxic environment and β-thalassemia, to identify two markedly different response dynamics for two erythroblast survival pathways in vivo. Induction of the antiapoptotic protein Bcl-x(L) is rapid but transient, while suppression of the proapoptotic protein Bim is slower but persistent. Similar to sensory adaptation, however, the Bcl-x(L) pathway "resets," allowing it to respond afresh to acute stress superimposed on a chronic stress stimulus. Using "knock-in" mouse models expressing mutant EpoRs, we found that adaptation in the Bcl-x(L) response occurs because of adaptation of its upstream regulator Stat5, both requiring the EpoR distal cytoplasmic domain. We conclude that survival pathways show previously unsuspected functional specialization for the acute and chronic phases of the stress response. Bcl-x(L) induction provides a "stop-gap" in acute stress, until slower but permanent pathways are activated. Furthermore, pathologic elevation of Bcl-x(L) may be the result of impaired adaptation, with implications for myeloproliferative disease mechanisms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22086418      PMCID: PMC3277355          DOI: 10.1182/blood-2011-07-365346

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  55 in total

1.  Constitutive activation of STAT5 and Bcl-xL overexpression can induce endogenous erythroid colony formation in human primary cells.

Authors:  Loïc Garçon; Christine Rivat; Chloé James; Catherine Lacout; Valérie Camara-Clayette; Valérie Ugo; Yann Lecluse; Annelise Bennaceur-Griscelli; William Vainchenker
Journal:  Blood       Date:  2006-05-09       Impact factor: 22.113

2.  Core erythropoietin receptor signals for late erythroblast development.

Authors:  Madhu P Menon; Jing Fang; Don M Wojchowski
Journal:  Blood       Date:  2005-12-06       Impact factor: 22.113

3.  Bcl-x(L) prevents apoptosis of late-stage erythroblasts but does not mediate the antiapoptotic effect of erythropoietin.

Authors:  Melissa M Rhodes; Prapaporn Kopsombut; Maurice C Bondurant; James O Price; Mark J Koury
Journal:  Blood       Date:  2005-05-17       Impact factor: 22.113

4.  The role of Janus Kinase 2 V617F mutation in extramedullary hematopoiesis of the spleen in neoplastic myeloid disorders.

Authors:  Pin-Pen Hsieh; Randy J Olsen; Dennis P O'Malley; Sergej N Konoplev; Jerry W Hussong; Cherie H Dunphy; Sherrie L Perkins; Liang Cheng; Pei Lin; Chung-Che Chang
Journal:  Mod Pathol       Date:  2007-07-20       Impact factor: 7.842

Review 5.  Life, death, BH3 profiles, and the salmon mousse.

Authors:  Douglas R Green
Journal:  Cancer Cell       Date:  2007-08       Impact factor: 31.743

6.  Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo.

Authors:  Ying Liu; Ramona Pop; Cameron Sadegh; Carlo Brugnara; Volker H Haase; Merav Socolovsky
Journal:  Blood       Date:  2006-03-09       Impact factor: 22.113

7.  A novel role for STAT1 in regulating murine erythropoiesis: deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution.

Authors:  Adrienne Halupa; Monica L Bailey; Kai Huang; Norman N Iscove; David E Levy; Dwayne L Barber
Journal:  Blood       Date:  2004-06-22       Impact factor: 22.113

Review 8.  Molecular insights into stress erythropoiesis.

Authors:  Merav Socolovsky
Journal:  Curr Opin Hematol       Date:  2007-05       Impact factor: 3.284

9.  Erythroid progenitor renewal versus differentiation: genetic evidence for cell autonomous, essential functions of EpoR, Stat5 and the GR.

Authors:  H Dolznig; F Grebien; E M Deiner; K Stangl; A Kolbus; B Habermann; M A Kerenyi; M Kieslinger; R Moriggl; H Beug; E W Müllner
Journal:  Oncogene       Date:  2006-05-11       Impact factor: 9.867

10.  Negative autoregulation by FAS mediates robust fetal erythropoiesis.

Authors:  Merav Socolovsky; Michael Murrell; Ying Liu; Ramona Pop; Ermelinda Porpiglia; Andre Levchenko
Journal:  PLoS Biol       Date:  2007-10       Impact factor: 8.029

View more
  22 in total

1.  Mitophagy is increased during erythroid differentiation in β-thalassemia.

Authors:  Limei Wu; Wei Xu; Luhong Xu; Qian Kong; Jianpei Fang
Journal:  Int J Hematol       Date:  2016-10-28       Impact factor: 2.490

Review 2.  β-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies.

Authors:  Stefano Rivella
Journal:  Haematologica       Date:  2015-04       Impact factor: 9.941

3.  GATA Factor-Regulated Samd14 Enhancer Confers Red Blood Cell Regeneration and Survival in Severe Anemia.

Authors:  Kyle J Hewitt; Koichi R Katsumura; Daniel R Matson; Prithvia Devadas; Nobuyuki Tanimura; Alexander S Hebert; Joshua J Coon; Jin-Soo Kim; Colin N Dewey; Sunduz Keles; Siyang Hao; Robert F Paulson; Emery H Bresnick
Journal:  Dev Cell       Date:  2017-08-07       Impact factor: 12.270

4.  Phospho-proteomic discovery of novel signal transducers including thioredoxin-interacting protein as mediators of erythropoietin-dependent human erythropoiesis.

Authors:  Matthew A Held; Emily Greenfest-Allen; Edward Jachimowicz; Christian J Stoeckert; Matthew P Stokes; Antony W Wood; Don M Wojchowski
Journal:  Exp Hematol       Date:  2020-04-04       Impact factor: 3.084

5.  A germline point mutation in Runx1 uncouples its role in definitive hematopoiesis from differentiation.

Authors:  Christopher R Dowdy; Dana Frederick; Sayyed K Zaidi; Jennifer L Colby; Jane B Lian; Andre J van Wijnen; Rachel M Gerstein; Janet L Stein; Gary S Stein
Journal:  Exp Hematol       Date:  2013-06-30       Impact factor: 3.084

6.  Isocitrate ameliorates anemia by suppressing the erythroid iron restriction response.

Authors:  Chanté L Richardson; Lorrie L Delehanty; Grant C Bullock; Claudia M Rival; Kenneth S Tung; Donald L Kimpel; Sara Gardenghi; Stefano Rivella; Adam N Goldfarb
Journal:  J Clin Invest       Date:  2013-07-25       Impact factor: 14.808

Review 7.  Anaemia in kidney disease: harnessing hypoxia responses for therapy.

Authors:  Mark J Koury; Volker H Haase
Journal:  Nat Rev Nephrol       Date:  2015-06-09       Impact factor: 28.314

8.  Erythropoietin critically regulates the terminal maturation of murine and human primitive erythroblasts.

Authors:  Jeffrey Malik; Ah Ram Kim; Kaitlin A Tyre; Anjuli R Cherukuri; James Palis
Journal:  Haematologica       Date:  2013-07-26       Impact factor: 9.941

Review 9.  Development and differentiation of the erythroid lineage in mammals.

Authors:  Jeffrey Barminko; Brad Reinholt; Margaret H Baron
Journal:  Dev Comp Immunol       Date:  2015-12-19       Impact factor: 3.636

Review 10.  What can we learn from ineffective erythropoiesis in thalassemia?

Authors:  Paraskevi Rea Oikonomidou; Stefano Rivella
Journal:  Blood Rev       Date:  2017-10-03       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.